Role of reactive oxygen species in injury-induced insulin resistance

Molecular Endocrinology

Volumn 25, Issue 3, 2011, Pages 492-502

  Zhai, Lidong ^a   Ballinger, Scott W ^a   Messina, Joseph L ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HYPERGLYCEMIA; INJURY; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LIVER; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOTTING, WESTERN; GENOTYPE; GLUCOSE TOLERANCE TEST; HEMORRHAGE; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; WOUNDS AND INJURIES;

MUS;

EID: 79952129516     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0224     Document Type: Article

References (50)

1. Abdul-Ghani MA, Jani R, Chavez A, Molina-Carrion M, Tripathy D, Defronzo RA 2009 Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 52:574-582
2. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, Rieusset J 2008 Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118:789-800 (Pubitemid 351206566)
3. Houstis N, Rosen ED, Lander ES 2006 Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944-948
4. Kumashiro N, Tamura Y, Uchida T, Ogihara T, Fujitani Y, Hirose T, Mochizuki H, Kawamori R, Watada H 2008 Impact of oxidative stress and peroxisome proliferator-activated receptor γ coactivator- 1α in hepatic insulin resistance. Diabetes 57:2083-2091
5. Abilés J, de la Cruz AP, Castaño J, Rodríguez-Elvira M, Aguayo E, Moreno-Torres R, Llopis J, Aranda P, Argüelles S, Ayala A, de la Quintana AM, Planells EM 2006 Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care 10:R146
6. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S, Tiganis T 2009 Reactive oxygen species enhance insulin sensitivity. Cell Metab 10:260-272
7. Veal EA, Day AM, Morgan BA 2007 Hydrogen peroxide sensing and signaling. Mol Cell 26:1-14 (Pubitemid 46578115)
8. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G 2003 Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannosebinding lectin levels. J Clin Endocrinol Metab 88:1082-1088 (Pubitemid 36337759)
9. Vogelzang M, Nijboer JM, van der Horst IC, Zijlstra F, ten Duis HJ, Nijsten MW 2006 Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 60:873-877; discussion 878-879
10. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, Rordorf GA 2009 Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke 40:1644-1652
11. Garcia BR, Tasker RC, Ramos Garcia PC, Piva JP, Dias XL 2007 Glycemic control and insulin therapy in sepsis and critical illness. J Pediatr (Rio J) 83:S128-S136
12. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS 2004 Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109:1497-1502 (Pubitemid 38420177)
13. Fahy BG, Sheehy AM, Coursin DB 2009 Glucose control in the intensive care unit. Crit Care Med 37:1769-1776
14. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
15. Nakae J, Accili D 1999 The mechanism of insulin action. J Pediatr Endocrinol Metab 12(Suppl 3):721-731 (Pubitemid 30002850)
16. White MF 1997 The insulin signalling system and the IRS proteins. Diabetologia 40:S2-S17 (Pubitemid 27306917)
17. Biddinger SB, Kahn CR 2006 From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 68:123-158
18. Pessin JE, Saltiel AR 2000 Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165-169 (Pubitemid 30483117)
19. Guzy RD, Mack MM, Schumacker PT 2007 Mitochondrial complex III is required for hypoxia-induced ROS production and gene transcription in yeast. Antioxid Redox Signal 9:1317-1328 (Pubitemid 47255011)
20. Nohl H, Gille L, Staniek K 2005 Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol 69:719-723 (Pubitemid 40248614)
21. Ikai I, Ozaki N, Shimahara Y, Wakashiro S, Tokunaga Y, Tanaka A, Ozawa K 1989 Significance of hepatic mitochondrial redox potential on the concentrations of plasma amino acids following hemorrhagic shock in rats. Circ Shock 27:63-72 (Pubitemid 19047177)
22. Lehnert M, Arteel GE, Smutney OM, Conzelmann LO, Zhong Z, Thurman RG, Lemasters JJ 2003 Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 19:345-351
23. Akgür FM, Brown MF, Zibari GB, McDonald JC, Epstein CJ, Ross CR, Granger DN 2000 Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol 279: H791-H797
24. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, Salvemini D 2003 On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 140:445-460
25. Ma Y, Wang P, Kuebler JF, Chaudry IH, Messina JL 2003 Hemorrhage induces the rapid development of hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 284:G107-G115 (Pubitemid 36076255)
26. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH, Messina JL 2004 Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-α. Endocrinology 145:5168-5176 (Pubitemid 39551138)
27. Xu J, Kim HT, Ma Y, Zhao L, Zhai L, Kokorina N, Wang P, Messina JL 2008 Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor-α. Endocrinology 149:2369-2382 (Pubitemid 351574510)
28. Li L, Thompson LH, Zhao L, Messina JL 2009 Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury. Endocrinology 150:24-32
29. Thompson LH, Kim HT, Ma Y, Kokorina N, Messina JL 2008 Acute muscle-type specific insulin resistance following injury. Mol Med 11-12:715-723
30. Hausladen A, Fridovich I 1996 Measuring nitric oxide and superoxide: rate constants for aconitase reactivity. Methods Enzymol 269:37-41 (Pubitemid 26295694)
31. Hausladen A, Fridovich I 1994 Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269:29405-29408 (Pubitemid 24365084)
32. Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD 1998 Transgenic models for the study of lung antioxidant defense: enhanced manganese- containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 18:538-547 (Pubitemid 128353628)
33. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I 2004 Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-1761 (Pubitemid 40385531)
34. Mollen KP, McCloskey CA, Tanaka H, Prince JM, Levy RM, Zuckerbraun BS, Billiar TR 2007 Hypoxia activates c-Jun N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes. Shock 28:270-277 (Pubitemid 47282017)
35. Gauuan PJ, Trova MP, Gregor-Boros L, Bocckino SB, Crapo JD, Day BJ 2002 Superoxide dismutase mimetics: synthesis and structure- activity relationship study of MnTBAP analogues. Bioorg Med Chem 10:3013-3021 (Pubitemid 34761881)
36. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336 (Pubitemid 35398190)
37. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ 2008 A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539-1543
38. Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK 2009 Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes 58:590-599
39. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M 2005 Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-661 (Pubitemid 40343077)
40. Carter EA 1998 Insulin resistance in burns and trauma. Nutr Rev 56:S170-S176 (Pubitemid 28069985)
41. Lange MP, Dahn MS, Jacobs LA 1985 The significance of hyperglycemia after injury. Heart Lung 14:470-472 (Pubitemid 15231369)
42. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
43. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M 2000 Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790 (Pubitemid 30212409)
44. Aberegg SK 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354:2069-2071
45. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461 (Pubitemid 43200296)
46. Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS 2006 Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc Natl Acad Sci USA 103:10741-10746 (Pubitemid 44078046)
47. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y, Hori M 2004 Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279:45803-45809 (Pubitemid 39491572)
48. Napoli R, Gibson L, Hirshman MF, Boppart MD, Dufresne SD, Horton ES, Goodyear LJ 1998 Epinephrine and insulin stimulate different mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Diabetes 47:1549-1554 (Pubitemid 28445341)
49. Gardner PR, Raineri I, Epstein LB, White CW 1995 Superoxide radical and iron modulate aconitase activity in mammalian cells. J Biol Chem 270:13399-13405
50. Zhai L, Messina JL 2009 Age and tissue specific differences in the development of acute insulin resistance following injury. J Endocrinol 203:365-374